MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO

Why It Matters

Interoperability underpins value‑based reimbursement and AI‑driven health innovations, so data‑flow gaps raise costs and limit outcomes. The Epic antitrust case could force broader data sharing, reshaping market competition.

Key Takeaways

• Particle Health aggregates data from over 70,000 healthcare organizations
• CMS interoperability framework rated B‑plus for data transmission
• Carequality processes >1 billion requests monthly, outpacing TEFCA
• Antitrust suit against Epic advances data‑access competition

Pulse Analysis

The United States has taken significant policy steps toward health‑data interoperability, from the 21st Century Cures Act’s information‑blocking penalties to the launch of TEFCA and CMS’s recent interoperability framework. These initiatives establish the legal “speed limits” and “roads” for data exchange, but enforcement remains uneven, leaving many providers disconnected from the broader network. As regulators tighten rules, the industry faces pressure to move beyond point‑to‑point transfers and deliver seamless, patient‑centric access.

Particle Health positions itself as a data‑intelligence hub that translates fragmented records into actionable clinical insights. By offering a single API that connects more than 70,000 hospitals, clinics and digital‑health firms, the company processes billions of data points and supports over 50 patient‑provider interactions per second. This scale enables clinicians to retrieve comprehensive histories quickly, a prerequisite for value‑based care models where reimbursement hinges on outcomes rather than volume. The firm’s participation in CMS’s health‑tech ecosystem and its focus on programmatic patient‑access APIs aim to close the gap between data availability and clinical utility.

Legal battles are now shaping the competitive landscape of health‑information exchange. The 2024 antitrust lawsuit against Epic, which alleges the EHR giant is leveraging market dominance to block payer‑platform competitors, marks a historic challenge to data‑blocking practices. Success could compel larger vendors to open APIs, fostering innovation from startups and AI developers. Simultaneously, state‑level suits, such as Texas’s action against Epic, reinforce the push for transparent, patient‑controlled data. Stakeholders watching these cases can anticipate stricter enforcement of information‑blocking rules and a faster transition toward truly interoperable, value‑driven health systems.